Neuro-Oncology News

Researchers who identified proteins that influence T-cell formation have leveraged their discovery to develop a process that boosts the efficacy of chimeric antigen receptor T-cell therapy for solid tumors.

Researchers at Massachusetts General Hospital have developed a new blood test to detect epidermal growth factor receptor mutations in patients with glioma — one of the most common brain cancers in adults.

Glioblastoma, the most common primary brain cancer, is known to be highly aggressive and deadly.

The FDA granted fast track designation to several oncology and hematology therapies.

Perhaps no one has been better prepared to become a leader in the field of cancer cellular immunotherapy than Marcela V. Maus, MD, PhD.

The FDA granted fast track and orphan drug designations to Alpheus Medical’s CV-01 delivery of sonodynamic therapy for treatment of recurrent glioblastoma.

American Society for Radiation Oncology has issued a guideline on use of radiation therapy to treat patients with brain metastases.

The FDA granted orphan drug designation to several therapies in development for oncology indications.

The oncolytic adenovirus DNX-2401 appeared safe and feasible among a small cohort of pediatric patients with diffuse intrinsic pontine glioma, according to study results published in The New England Journal of Medicine.

Crystal L. Mackall, MD, believes she has an "unusual pedigree" for someone in her position.